Get the Stockscreener App
1.21
0.82%
-0.01
Theratechnologies Inc stock is traded at $1.21, with a volume of 2,930.
It is down -0.82% in the last 24 hours and down -11.03% over the past month.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
See More
Previous Close:
$1.22
Open:
$1.21
24h Volume:
2,930
Relative Volume:
0.09
Market Cap:
$56.10M
Revenue:
$81.76M
Net Income/Loss:
$-23.96M
P/E Ratio:
-0.9918
EPS:
-1.22
Net Cash Flow:
$-7.50M
1W Performance:
+0.00%
1M Performance:
-11.03%
6M Performance:
-9.02%
1Y Performance:
-12.95%
1-Day Range:
$1.21
$1.21
1-Week Range:
$1.16
$1.22
52-Week Range:
$1.08
$2.58
Theratechnologies Inc Stock (THTX) Company Profile
Compare THTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| THTX | 1.21 | 56.10M | 81.76M | -23.96M | -7.50M | -1.22 |
| VRTX | 448.16 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 745.35 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.97 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.15 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.82 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Downgrade | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Stock (THTX) Latest News
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Up 26.8% in October - MarketBeat
Theratechnologies (TSE:TH) Share Price Passes Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Net Present Value Model: Theratechnologies Inc’s Sudocetaxel Zendusortide - GlobalData
Theratechnologies (TSE:TH) Stock Passes Below Fifty Day Moving AverageTime to Sell? - MarketBeat
Short Interest in Theratechnologies Inc. (NASDAQ:THTX) Rises By 226.0% - MarketBeat
Closing Bell: Theratechnologies Down On Monday (TH) - Barchart
THTX upgraded at Research Capital - Cantech Letter
Theratechnologies (TSE:TH) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV - The Manila Times
Theratechnologies reports use of HIV drug in severe cases - Investing.com
Theratechnologies reports use of HIV drug in severe cases By Investing.com - Investing.com South Africa
Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance - GlobeNewswire
Theratechnologies Inc. Forecasted to Earn FY2024 Earnings of $0.04 Per Share (NASDAQ:THTX) - Defense World
Cantor Fitzgerald Weighs in on Theratechnologies Inc.'s FY2024 Earnings (NASDAQ:THTX) - MarketBeat
Earnings call: Theratechnologies reports Q3 profit, raises EBITDA guidance - Investing.com
Theratechnologies (NASDAQ:THTX) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Theratechnologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Theratechnologies (TSE:TH) Stock Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Theratechnologies Inc (THTX) Q3 2024 Earnings Call Highlights: Strong Profitability Amid ... - Yahoo Finance
Theratechnologies: Fiscal Q3 Earnings Snapshot - mySA
Theratechnologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2024 - Marketscreener.com
Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024 - GlobeNewswire
Earnings to Watch: Theratechnologies Inc (TSX:TH) Reports Q3 202 - GuruFocus.com
Theratechnologies to Present Data at IDWeek 2024 - GlobeNewswire
Theratechnologies (TH) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Theratechnologies Inc. (NASDAQ:THTX) Short Interest Update - MarketBeat
Theratechnologies (TSE:TH) Shares Pass Below Two Hundred Day Moving Average of $1.83 - MarketBeat
Theratechnologies (TSE:TH) Stock Price Crosses Below Two Hundred Day Moving Average of $1.83 - Defense World
Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update - Brantford Expositor
Theratechnologies Braces for Supply Disruption - TipRanks
Thermon Group Holdings, Inc. (NYSE:THR) Shares Purchased by Victory Capital Management Inc. - Defense World
Thryv Holdings director Amer acquires $22,152 in company stock - Investing.com India
Selling Buzz: Tenet Healthcare Corp. [THC] Principal Accounting Officer Ramsey R. Scott sells 11,599 shares of the company – Knox Daily - Knox Daily
Tenet Healthcare stock hits 52-week high at $166.9 amid robust growth - Investing.com
Insider Selling: Gentherm Incorporated (NASDAQ:THRM) CEO Sells 4,402 Shares of Stock - MarketBeat
Hellenic Telecommunications Organization (OTCMKTS:HLTOY) Sets New 52-Week High at $8.50 - MarketBeat
Tenet Healthcare (NYSE:THC) Sets New 52-Week High at $167.29 - MarketBeat
Hercules Capital (HTGC) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance
Gentherm CEO sells over $750k in company stock - Investing.com India
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
Teralys Capital says it “should” hit $570-million fund-of-funds target by end of yearBetaKit - BetaKit - Canadian Startup News
Ternium: Still Not A Buy As Near-Term Growth Prospects Remain Unfavorable - Seeking Alpha
Theratechnologies Faces Potential Supply Disruption For Its Top Selling Drug, Warns of Revenue Impact Due To Manufacturing Delays - AOL
Theratechnologies Inc Stock (THTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):